Forte Biosciences Statistics
Total Valuation
FBRX has a market cap or net worth of $643.04 million. The enterprise value is $566.09 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FBRX has 24.48 million shares outstanding. The number of shares has increased by 404.74% in one year.
| Current Share Class | 19.60M |
| Shares Outstanding | 24.48M |
| Shares Change (YoY) | +404.74% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 51.06% |
| Float | 22.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.84 |
| P/TBV Ratio | 10.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.88
| Current Ratio | 3.88 |
| Quick Ratio | 3.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -122.28% and return on invested capital (ROIC) is -77.84%.
| Return on Equity (ROE) | -122.28% |
| Return on Assets (ROA) | -61.19% |
| Return on Invested Capital (ROIC) | -77.84% |
| Return on Capital Employed (ROCE) | -113.91% |
| Weighted Average Cost of Capital (WACC) | 21.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.65M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FBRX has paid $1.04 million in taxes.
| Income Tax | 1.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +291.68% in the last 52 weeks. The beta is 3.20, so FBRX's price volatility has been higher than the market average.
| Beta (5Y) | 3.20 |
| 52-Week Price Change | +291.68% |
| 50-Day Moving Average | 28.52 |
| 200-Day Moving Average | 20.41 |
| Relative Strength Index (RSI) | 41.97 |
| Average Volume (20 Days) | 405,498 |
Short Selling Information
The latest short interest is 843,652, so 3.45% of the outstanding shares have been sold short.
| Short Interest | 843,652 |
| Short Previous Month | 892,176 |
| Short % of Shares Out | 3.45% |
| Short % of Float | 3.73% |
| Short Ratio (days to cover) | 2.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -70.66M |
| Pretax Income | -68.34M |
| Net Income | -69.38M |
| EBITDA | -70.59M |
| EBIT | -70.66M |
| Earnings Per Share (EPS) | -$4.71 |
Full Income Statement Balance Sheet
The company has $76.96 million in cash and n/a in debt, giving a net cash position of $76.96 million or $3.14 per share.
| Cash & Cash Equivalents | 76.96M |
| Total Debt | n/a |
| Net Cash | 76.96M |
| Net Cash Per Share | $3.14 |
| Equity (Book Value) | 60.99M |
| Book Value Per Share | 3.42 |
| Working Capital | 59.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$50.88 million and capital expenditures -$116,000, giving a free cash flow of -$51.00 million.
| Operating Cash Flow | -50.88M |
| Capital Expenditures | -116,000 |
| Depreciation & Amortization | 64,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -51.00M |
| FCF Per Share | -$2.08 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FBRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -404.74% |
| Shareholder Yield | -404.74% |
| Earnings Yield | -10.79% |
| FCF Yield | -7.93% |
Analyst Forecast
The average price target for FBRX is $67.00, which is 155.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $67.00 |
| Price Target Difference | 155.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 28, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 28, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |